Maria Sofia Molonia

Dr. Maria Sofia Molonia

University of Messina, Messina, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 June 2019 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
CMClaudia Muscarà
Claudia Muscarà
MMMaria Sofia Molonia
Maria Sofia Molonia
Antonio SpecialeAntonio Speciale
Antonio Speciale
RBRomina Bashllari
Romina Bashllari
FCFrancesco Cimino
Francesco Cimino
MCMariateresa Cristani
Mariateresa Cristani

8 March 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
DFDaniela Ferrari
Daniela Ferrari
Francesco CiminoFrancesco Cimino
Francesco Cimino
Deborah FratantonioDeborah Fratantonio
Deborah Fratantonio
MMMaria Sofia Molonia
Maria Sofia Molonia
RBRomina Bashllari
Romina Bashllari
Antonio SpecialeAntonio Speciale
Antonio Speciale
Intestinal epithelium represents a protective physical barrier and actively contributes to the mucosal immune system. Polarized basolateral intestinal secretion of inflammatory mediators, followed by activation of NF-κB signaling and inflammatory pathways in endothelial cells, efficiently triggers extravasation of neutrophils from the vasculature, therefore contributing to the development and maintenance of intestinal inflammation. Proper regulation of NF-κB activation at the epithelial interface is crucial for the maintenance of physiological tissue homeostasis. Many papers reported that anthocyanins, a group of compounds belonging to flavonoids, possess anti-inflammatory effects and modulate NF-κB activity. In this study, by using a coculture in vitro system, we aimed to evaluate the effects of TNF-α-stimulated intestinal cells on endothelial cells activation, as well as the protective effects of cyanidin-3-glucoside (C3G). In this model, TNF-αinduced nuclear translocation of NF-κB and TNF-αand IL-8 gene expression in Caco-2 cells, whereas C3G pretreatment dose-dependently reduced these effects. Furthermore, TNF-α-stimulated Caco-2 cells induced endothelial cells activation with increased E-selectin and VCAM-1 mRNA, leukocyte adhesion, and NF-κB levels in HUVECs, which were inhibited by C3G. We demonstrated that selective inhibition of the NF-κB pathway in epithelial cells represents the main mechanism by which C3G exerts these protective effects. Thus, anthocyanins could contribute to the management of chronic gut inflammatory diseases.

1 September 2020 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
MMMaria Sofia Molonia
Maria Sofia Molonia
COCristina Occhiuto
Cristina Occhiuto
CMClaudia Muscarà
Claudia Muscarà
Antonio SpecialeAntonio Speciale
Antonio Speciale
RBRomina Bashllari
Romina Bashllari
MCMariateresa Cristani
Mariateresa Cristani

16 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Nicola MICALENicola MICALE
Nicola MICALE
Andrea CitarellaAndrea Citarella
Andrea Citarella
MMMaria Sofia Molonia
Maria Sofia Molonia
Antonio SpecialeAntonio Speciale
Antonio Speciale
Francesco CiminoFrancesco Cimino
Francesco Cimino
CMCristani Mariateresa
Cristani Mariateresa
This review deals with hydrogels as soft and biocompatible vehicles for the delivery of plant-derived (poly)phenols, compounds with low general toxicity and an extraordinary and partially unexplored wide range of biological properties, whose use presents some major issues due to their poor bioavailability and water solubility. Hydrogels are composed of polymeric networks which are able to absorb large amounts of water or biological fluids while retaining their three-dimensional structure. Apart from this primary swelling capacity, hydrogels may be easily tailored in their properties according to the chemical structure of the polymeric component in order to obtain smart delivery systems that can be responsive to various internal/external stimuli. The functionalization of the polymeric component of hydrogels may also be widely exploited to facilitate the incorporation of bioactive compounds with different physicochemical properties into the system. Several prototype hydrogel systems have been designed for effective polyphenol delivery and potential employment in the treatment of human diseases. Therefore, the inherent features of hydrogels have been the focus of considerable research efforts over the past few decades. Herein, we review the most recent advances in (poly)phenol-loaded hydrogels by analyzing them primarily from the therapeutic perspective and highlighting the innovative aspects in terms of design and chemistry.

8 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Antonio SpecialeAntonio Speciale
Antonio Speciale
CMClaudia Muscarà
Claudia Muscarà
MMMaria Sofia Molonia
Maria Sofia Molonia
CMCristani Mariateresa
Cristani Mariateresa
Francesco CiminoFrancesco Cimino
Francesco Cimino
Antonina SaijaAntonina Saija
Antonina Saija
Liver cancer is one of the most common causes of cancer mortality worldwide. Chemotherapy and radiotherapy are the conventional therapies generally employed in patients with liver tumors. The major issue associated with the administration of chemotherapeutics is their high toxicity and lack of selectivity, leading to systemic toxicity that can be detrimental to the patient’s quality of life. An important approach to the development of original liver-targeted therapeutic products takes advantage of the employment of biologically active ligands able to bind specific receptors on the cytoplasmatic membranes of liver cells. In this perspective, glycyrrhetinic acid (GA), a pentacyclic triterpenoid present in roots and rhizomes of licorice, has been used as a ligand for targeting the liver due to the expression of GA receptors on the sinusoidal surface of mammalian hepatocytes, so it may be employed to modify drug delivery systems (DDSs) and obtain better liver or hepatocyte drug uptake and efficacy. In the current review, we focus on the most recent and interesting research advances in the development of GA-based hybrid compounds and DDSs developed for potential employment as efficacious therapeutic options for the treatment of hepatic cancer.